These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 7520963)
1. Towards a vaccine for rheumatic fever: identification of a conserved target epitope on M protein of group A streptococci. Pruksakorn S; Currie B; Brandt E; Martin D; Galbraith A; Phornphutkul C; Hunsakunachai S; Manmontri A; Good MF Lancet; 1994 Sep; 344(8923):639-42. PubMed ID: 7520963 [TBL] [Abstract][Full Text] [Related]
2. New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population. Brandt ER; Sriprakash KS; Hobb RI; Hayman WA; Zeng W; Batzloff MR; Jackson DC; Good MF Nat Med; 2000 Apr; 6(4):455-9. PubMed ID: 10742155 [TBL] [Abstract][Full Text] [Related]
3. Synthetic peptide vaccine against mucosal colonization by group A streptococci. I. Protection against a heterologous M serotype with shared C repeat region epitopes. Bessen D; Fischetti VA J Immunol; 1990 Aug; 145(4):1251-6. PubMed ID: 1696296 [TBL] [Abstract][Full Text] [Related]
4. Mapping a conserved conformational epitope from the M protein of group A streptococci. Relf WA; Cooper J; Brandt ER; Hayman WA; Anders RF; Pruksakorn S; Currie B; Saul A; Good MF Pept Res; 1996; 9(1):12-20. PubMed ID: 8727479 [TBL] [Abstract][Full Text] [Related]
5. Identification of T cell autoepitopes that cross-react with the C-terminal segment of the M protein of group A streptococci. Pruksakorn S; Currie B; Brandt E; Phornphutkul C; Hunsakunachai S; Manmontri A; Robinson JH; Kehoe MA; Galbraith A; Good MF Int Immunol; 1994 Aug; 6(8):1235-44. PubMed ID: 7981150 [TBL] [Abstract][Full Text] [Related]
6. Type-specific antibodies to structurally defined fragments of streptococcal M proteins in patients with acute rheumatic fever. Bisno AL; Berrios X; Quesney F; Monroe DM; Dale JB; Beachey EH Infect Immun; 1982 Nov; 38(2):573-9. PubMed ID: 6754620 [TBL] [Abstract][Full Text] [Related]
7. Mapping the minimal murine T cell and B cell epitopes within a peptide vaccine candidate from the conserved region of the M protein of group A streptococcus. Hayman WA; Brandt ER; Relf WA; Cooper J; Saul A; Good MF Int Immunol; 1997 Nov; 9(11):1723-33. PubMed ID: 9418133 [TBL] [Abstract][Full Text] [Related]
8. Immune response against M protein-conserved region peptides from prevalent group A Streptococcus in a North Indian population. Gupta VK; Sekhar S; Dhanda V; Toor D; Kumar R; Chakraborti A J Microbiol Immunol Infect; 2016 Jun; 49(3):352-8. PubMed ID: 25087198 [TBL] [Abstract][Full Text] [Related]
9. Conserved T and B cell epitopes on the M protein of group A streptococci. Induction of bactericidal antibodies. Pruksakorn S; Galbraith A; Houghten RA; Good MF J Immunol; 1992 Oct; 149(8):2729-35. PubMed ID: 1383324 [TBL] [Abstract][Full Text] [Related]
10. Protective and nonprotective epitopes from amino termini of M proteins from Australian aboriginal isolates and reference strains of group A streptococci. Brandt ER; Teh T; Relf WA; Hobb RI; Good MF Infect Immun; 2000 Dec; 68(12):6587-94. PubMed ID: 11083769 [TBL] [Abstract][Full Text] [Related]
11. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Brandt ER; Hayman WA; Currie B; Carapetis J; Jackson DC; Do KA; Good MF Int Immunol; 1999 Apr; 11(4):569-76. PubMed ID: 10323210 [TBL] [Abstract][Full Text] [Related]
12. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Brandt ER; Hayman WA; Currie B; Carapetis J; Wood Y; Jackson DC; Cooper J; Melrose WD; Saul AJ; Good MF Immunology; 1996 Nov; 89(3):331-7. PubMed ID: 8958044 [TBL] [Abstract][Full Text] [Related]
13. Antigenic epitope mapping of the M24 protein of Streptococcus pyogenes: implications for serodiagnosis of rheumatic fever. Norton RE; Heuzenroeder M; Manning PA FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):267-71. PubMed ID: 9116645 [TBL] [Abstract][Full Text] [Related]
14. Bactericidal activity of M protein conserved region antibodies against group A streptococcal isolates from the Northern Thai population. Yoonim N; Olive C; Pruksachatkunakorn C; Pruksakorn S BMC Microbiol; 2006 Aug; 6():71. PubMed ID: 16895610 [TBL] [Abstract][Full Text] [Related]
16. Protection of mice from group A streptococcal infection by intranasal immunisation with a peptide vaccine that contains a conserved M protein B cell epitope and lacks a T cell autoepitope. Olive C; Clair T; Yarwood P; Good MF Vaccine; 2002 Jun; 20(21-22):2816-25. PubMed ID: 12034109 [TBL] [Abstract][Full Text] [Related]
17. Type-specific antibodies to purified streptococcal M proteins from potentially rheumatogenic M-types in patients with rheumatic fever and rheumatic heart disease. Thakur A; Singhal S; Prakash K J Med Microbiol; 1996 Dec; 45(6):483-9. PubMed ID: 8958254 [TBL] [Abstract][Full Text] [Related]
18. Influence of intranasal immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A streptococci. Bessen D; Fischetti VA Infect Immun; 1988 Oct; 56(10):2666-72. PubMed ID: 2458320 [TBL] [Abstract][Full Text] [Related]
19. Human antibodies to the conserved region of the M protein: opsonization of heterologous strains of group A streptococci. Brandt ER; Hayman WA; Currie B; Pruksakorn S; Good MF Vaccine; 1997 Nov; 15(16):1805-12. PubMed ID: 9364687 [TBL] [Abstract][Full Text] [Related]
20. The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococci. Jones KF; Fischetti VA J Exp Med; 1988 Mar; 167(3):1114-23. PubMed ID: 2450950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]